Gluconig
Natural health product licensed in Canada
- Other names
- Black-Sea, Gluco-Nig, MJ Tonic spécialisé Gluconig
- Licence holder
- Phytothera Inc.
- NPN or DIN-HM
- 80087435
- Status
- Active licence
- Licence date
- 27 July 2018
- Revision date
- 27 August 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Nigella sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les enfants, adolescents, femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ascophyllum nodosum/Fucus vesiculosus blend Source : Thallus Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 5 g Potency : 10 % Poly(phénols) | 250 mg | Not calculated |
| Nigella sativa Source : Grain | 500 mg | Not calculated |
| Ascophyllum nodosum/Fucus vesiculosus blend Source : Thallus Potency : 75 mcg Iodine | Not specified | Not calculated |
Non-medicinal ingredients
Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Aide au maintien santé d'un taux de glucose sanguin. Aide à réduire l'index glycémique des aliments ingérés.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Ne pas utiliser ce produit si vous tentez de devenir enceinte, êtes enceinte, ou allaitante.
- Précautions et mises en garde
Cessez l'utilisation si vous manifestez des désordres gastro-intestinaux. Consulter un praticien en soins de santé si vous avez de L'hypotension ou de l'hypertension ou si vous prenez des médicaments antihypertensifs. Ne pas utiliser si vous êtes allergique à l'iode. Consulter un praticien en soins de santé si vous souffrez de diabète. Arrêter l'utilisation et consulter un praticien en soins de santé si vous ressentez des symptômes d'hypoglycémie, incluant des sentiments d'anxiété, de vertiges, de tremblements, de sueurs, de nausées ou de maux de tête.
Source
Official Health Canada record, licence 80087435
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.